Involvement of DNA Damage Response via the Ccndbp1-Atm-Chk2 Pathway in Mice with Dextran-Sodium-Sulfate-Induced Colitis.
Ryoko HorigomeKenya KamimuraYusuke NiwaKohei OgawaKen-Ichi MizunoKoichi FujisawaNaoki YamamotoTaro TakamiTomoyuki SuganoAkira SakamakiHiroteru KamimuraMasaaki TakamuraShuji TeraiPublished in: Journal of clinical medicine (2022)
The dextran sodium sulfate (DSS)-induced colitis mouse model has been widely utilized for human colitis research. While its mechanism involves a response to double-strand deoxyribonucleic acid (DNA) damage, ataxia telangiectasia mutated (Atm)-checkpoint kinase 2 (Chk2) pathway activation related to such response remains unreported. Recently, we reported that cyclin D1-binding protein 1 ( Ccndbp1 ) activates the pathway reflecting DNA damage in its knockout mice. Thus, this study aimed to examine the contribution of Ccndbp1 and the Atm-Chk2 pathway in DSS-induced colitis. We assessed the effect of DSS-induced colitis on colon length, disease activity index, and histological score and on the Atm-Chk2 pathway and the subsequent apoptosis in Ccndbp1 -knockout mice. DSS-induced colitis showed distal colon-dominant Atm and Chk2 phosphorylation, increase in TdT-mediated dUTP-biotin nick end labeling and cleaved caspase 3-positive cells, and histological score increase, causing disease activity index elevation and colon length shortening. These changes were significantly ameliorated in Ccndbp1 -knockout mice. In conclusion, Ccndbp1 contributed to Atm-Chk2 pathway activation in the DSS-induced colitis mouse model, causing inflammation and apoptosis of mucosal cells in the colon.
Keyphrases
- dna damage response
- dna damage
- dna repair
- disease activity
- oxidative stress
- cell cycle arrest
- induced apoptosis
- rheumatoid arthritis
- systemic lupus erythematosus
- mouse model
- cell death
- rheumatoid arthritis patients
- endoplasmic reticulum stress
- ankylosing spondylitis
- endothelial cells
- binding protein
- metabolic syndrome
- cell cycle
- early onset
- skeletal muscle
- cell proliferation
- insulin resistance
- induced pluripotent stem cells